Skip to Main Content

Author Details

Mark J Dunning
The Medical School, The University of Sheffield
2007
42
27
PMIDPaper TitleJournal TitlePublished Year
36400790Hyaluronan nanoscale clustering and Hyaluronan synthase 2 expression are linked to the invasion of child fibroblasts and infantile fibrosarcoma in vitro and in vivo.Sci Rep2022
36992918SpheroidAnalyseR-an online platform for analyzing data from 3D spheroids or organoids grown in 96-well plates.J Biol Methods2022
34069294Distinct Concentration-Dependent Molecular Pathways Regulate Bone Cell Responses to Cobalt and Chromium Exposure from Joint Replacement Prostheses.Int J Mol Sci2021
32212285The failure of microglia to digest developmental apoptotic cells contributes to the pathology of RNASET2-deficient leukoencephalopathy.Glia2020
30426503Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.J Pathol2019
29437778Identification of potential therapeutic targets in prostate cancer through a cross-species approach.EMBO Mol Med2018
30400059Neuroendocrine differentiation of prostate cancer leads to PSMA suppression.Endocr Relat Cancer2018
27815082Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.Eur Urol2017
28292578Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].EBioMedicine2017
28286059Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App.EBioMedicine2017
26950096Gene regulatory mechanisms underpinning prostate cancer susceptibility.Nat Genet2016
26572708The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.Eur Urol2016
25169931A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.Mol Oncol2015
26501111Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.EBioMedicine2015
258538005-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.Genome Biol2015
25560400HES5 silencing is an early and recurrent change in prostate tumourigenesis.Endocr Relat Cancer2015
24952744Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.Nat Genet2014
25456371Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.Lancet Oncol2014
25164602Genome-driven integrated classification of breast cancer validated in over 7,500 samples.Genome Biol2014
23484797Analysis of circulating tumor DNA to monitor metastatic breast cancer.N Engl J Med2013
24297747Loss of centrioles causes chromosomal instability in vertebrate somatic cells.J Cell Biol2013
22217937Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.Nature2012
23100629Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling.Sci Transl Med2012
22912679Calling sample mix-ups in cancer population studies.PLoS One2012
22522925The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.Nature2012
22513257Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.Breast Cancer Res2012
21337521ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium.EMBO Mol Med2011
22144879BeadArray expression analysis using bioconductor.PLoS Comput Biol2011
19923232A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data.Nucleic Acids Res2010
20688273The importance of platform annotation in interpreting microarray data.Lancet Oncol2010
20925945The cost of reducing starting RNA quantity for Illumina BeadArrays: a bead-level dilution experiment.BMC Genomics2010
20423502Identification and correction of previously unreported spatial phenomena using raw Illumina BeadArray data.BMC Bioinformatics2010
19153169Considerations for the processing and analysis of GoldenGate-based two-colour Illumina platforms.Stat Methods Med Res2009
19995423The pitfalls of platform comparison: DNA copy number array technologies assessed.BMC Genomics2009
18254947Statistical issues in the analysis of Illumina data.BMC Bioinformatics2008
18953044BASH: a tool for managing BeadArray spatial artefacts.Bioinformatics2008
18588681PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes.Breast Cancer Res2008
18710543Spike-in validation of an Illumina-specific variance-stabilizing transformation.BMC Res Notes2008
17289997Relative impact of nucleotide and copy number variation on gene expression phenotypes.Science2007
17873874Population genomics of human gene expression.Nat Genet2007
17586828beadarray: R classes and methods for Illumina bead-based data.Bioinformatics2007
17922911MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.Genome Biol2007
  • 1 - 42 of 42

Recommended Authors

The Walter and Eliza Hall Institute of Medical Research
Career Start Year 2011
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 2011
Number of shared co-authors 5
Roswell Park Cancer Institute, University of Buffalo
Career Start Year 2010
Number of shared co-authors 1
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 15
Department of Bioinformatics and Clinical Systems
Career Start Year 2006
Number of shared co-authors 0
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2005
Number of shared co-authors 0
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 3
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2003
Number of shared co-authors 1
Center for Cancer Innovation, University of Washington
Career Start Year 2003
Number of shared co-authors 7
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 4
Dana-Farber Cancer Institute
Career Start Year 2001
Number of shared co-authors 5
University of Pittsburgh School of Public Health
Career Start Year 2001
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 2
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 5
The University of Sydney
Career Start Year 2001
Number of shared co-authors 1
University of Wisconsin-Madison
Career Start Year 1999
Number of shared co-authors 0
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 13
University of Zurich
Career Start Year 1997
Number of shared co-authors 4
Technische Universitat Munchen
Career Start Year 1995
Number of shared co-authors 3
The University of Melbourne
Career Start Year 1992
Number of shared co-authors 3
University of California San Diego
Career Start Year 1992
Number of shared co-authors 6
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 2
Harvard T. H. Chan School of Public Health
Career Start Year 1989
Number of shared co-authors 5
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 3
Nanfang Hospital and Basic Medical College, Southern Medical University
Career Start Year 1987
Number of shared co-authors 9

Collaborators

University of St Andrews
Co-authored papers 20
Irving Institute for Cancer Dynamics, Columbia University
Co-authored papers 15
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 14
University of Oxford
Co-authored papers 10
Stanford University School of Medicine
Co-authored papers 9
University of Oxford, John Radcliffe Hospital
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
The University of Melbourne
Co-authored papers 7
University of Oxford
Co-authored papers 6
University of British Columbia
Co-authored papers 6
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 6
University of Cambridge
Co-authored papers 6
Queen's University Belfast
Co-authored papers 5
University College London
Co-authored papers 4
University College London
Co-authored papers 4
Norwich Medical School, University of East Anglia
Co-authored papers 4
Karolinska Institute
Co-authored papers 4
Karolinska Institute
Co-authored papers 4
Karolinska Institute
Co-authored papers 4
University of Cambridge
Co-authored papers 4
The Institute of Cancer Research
Co-authored papers 3
Co-authored papers 3
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 3
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 3
University of Pennsylvania
Co-authored papers 3
University of California los angeles
Co-authored papers 3
University College London
Co-authored papers 2
UCL Cancer Institute, University College London
Co-authored papers 2
University of Geneva
Co-authored papers 2
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 2